NCT06110442

Brief Summary

The proposed study will predict a patients' risk of having osteoporosis by using a combination of the IBEX BH (Bone Health) software outputs and other clinical risk factors such as age, gender, medical history and lifestyle. A comparison will be made between the IBEX BH prediction and the one calculated in current clinical practice using a tool called FRAX (Fracture Risk Assessment Tool) which combines clinical risk factors with results from a Dual Energy X-ray Absorptiometry (DXA) assessment. The study involves conducting these assessments on several new anatomies including Knee, Ankle and Pelvis, to extend the market reach and clinical utility of IBEX BH. The expected outcome of the study is that the IBEX BH will offer better decision support to clinicians in terms of referral on for a DXA scan or osteoporosis investigations than available today.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
497

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 31, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

1.5 years

First QC Date

September 20, 2023

Last Update Submit

January 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • T-scores as calculated by IbexBH and DXA

    2 hours on 1 visit only

Secondary Outcomes (1)

  • Estimated 10-year risk of major osteoporotic fracture as outputted by FRAX (with and without DXA aBMD (Areal Bone Mineral Density) and IbexBH)

    2 hours on same visit as above

Interventions

A software application applied to radiographs

Eligibility Criteria

Age20 Years - 120 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Representative population

You may qualify if:

  • Male or female
  • years of age or over

You may not qualify if:

  • Women who are pregnant or are breastfeeding.
  • Participants who have sustained fractures in both hips.
  • Unwilling or unable to provide informed consent.
  • For the collection of healthy-normal data in the study.
  • Male or female
  • years of age
  • Women who are pregnant or are breastfeeding.
  • Participants who have sustained fractures in both hips.
  • Unwilling or unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Exeter

Exeter, United Kingdom

Location

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 20, 2023

First Posted

October 31, 2023

Study Start

July 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 20, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations